Raggruppamento Secondario: Distrofia Muscolare di Duchenne

Filtra

Data

The relationship between deficit in digit span and genotype in nonsense mutation Duchenne muscular dystrophy

Ataluren treatment of patients with nonsense mutation dystrophinopathy.

Long-Term Safety and Efficacy Data of Golodirsen in Ambulatory Patients with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A First-in-human, Multicenter, Two-Part, Open-Label, Phase 1/2 Trial

Management of motor rehabilitation in individuals with muscular dystrophies. 1(st) Consensus Conference report from UILDM – Italian Muscular Dystrophy Association (Rome, January 25-26, 2019)

Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study

Patient reported outcome measure for upper limb in Duchenne muscular dystrophy: correlation with PUL2.0

Upper Limb Changes in DMD Patients Amenable to Skipping Exons 44, 45, 51 and 53: A 24-Month Study

Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability?

A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable?

Good response to the late treatment with ataluren in a boy with Duchenne muscular dystrophy: could the previous mild course of the disease have affected the outcome?

Torna in alto